nDatalyze Corp.
$0.08$0.00 (0.0%)
nDatalyze Corp.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
OTC · IDYLF · USD
Stock price, earnings
Quote as of Oct 28, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Imaging Dynamics Company Ltd.’s quoted price sits in the lower half of its reported 52-week range, 21.67% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Imaging Dynamics Company Ltd.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Imaging Dynamics Company Ltd. operates as a medical technology firm, supplying digital radiography solutions throughout the Americas and on a global scale. Its product portfolio encompasses a range of imaging detectors, including flat panel models branded as Aquarius 8600 for medical use and VetnovaXion for veterinary applications. Furthermore, the company develops specialized image processing software: Magellan for human medical diagnostics and Sirius for veterinary imaging. Additionally, Imaging Dynamics provides comprehensive digital radiography (DR) systems. These include the 1600 Plus X-Series, an integrated solution featuring a floor-mounted U-arm multi-axis positioning device, complete with an X-ray tube, collimator, and generator. Veterinary-specific DR systems are also part of its offerings. These products are distributed through a robust network comprising independent dealers, value-added distributors, and original equipment manufacturer (OEM) partners. Originally established as Imaging Dynamics Corporation in 1995, the company adopted its current name, Imaging Dynamics Company Ltd., in October 2001. Its corporate headquarters are situated in Toronto, Canada.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 07:54 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$0.08$0.00 (0.0%)
nDatalyze Corp.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.01$0.00 (0.0%)
Modern Mobility Aids, Inc.’s quoted price sits in the lower half of its reported 52-week range, 75.0% below the high.
€0.03-€0.00 (-1.47%)
Biophytis S.A.’s quoted price sits in the lower half of its reported 52-week range, 79.12% below the high.
$0.02$0.00 (0.0%)
Mednow Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.01$0.00 (0.0%)
Verisante Technology Inc.’s quoted price sits in the upper half of its reported 52-week range, 23.08% below the high.
$0.00$0.00 (0.0%)
Southern Home Medical, Inc.’s quoted price sits in the lower half of its reported 52-week range, 50.0% below the high.
$0.00$0.00 (0.0%)
Stemtech Corporation’s quoted price sits in the lower half of its reported 52-week range, 98.0% below the high.
$0.00$0.00 (0.0%)
Bangi Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.